Abstract
Of 1,455 unique patients in U.S. intensive care units (ICUs), 4% were rectally colonized with CRE on admission. A total of 297 patients were initially negative for carbapenem-resistant Enterobacteriaceae (CRE) and remained in the ICU long enough to contribute additional swabs; 22% of these patients had a subsequent CRE-positive swab, with a median time to CRE colonization of 13 days (interquartile range, 7 to 21 days). Patients colonized with carbapenemase-producing CRE were more likely than those colonized with non-carbapenemase-producing CRE to develop CRE infections during their hospitalizations (36% versus 3%; P 0.05).
Original language | English (US) |
---|---|
Article number | e00757-19 |
Journal | Antimicrobial agents and chemotherapy |
Volume | 63 |
Issue number | 8 |
DOIs | |
State | Published - 2019 |
Keywords
- CRE
- Carbapenem resistance
- ICU
- Multidrug-resistant organisms
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases